Regulation of IL-2 Gene Expression in T Cell Anergy - Daniel Mueller

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of General Medical Sciences (NIGMS)
Type: Research Project (R01)
Project #: 1R01GM054706-01
Application #: 2194043
Study Section: Special Emphasis Panel (ZRG2-ALY (01))

Project Start: 1996-07-01
Project End: 2000-06-30
Budget Start: 1996-07-01
Budget End: 1997-06-30
Support Year: 1
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: University of Minnesota Twin Cities
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #: 168559177

City: Minneapolis
State: MN
Country: United States
Zip Code: 55455

Related projects


NIH 2005 R01 GM	Regulation of IL-2 Gene Expression in T-cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities	$297,000
NIH 2004 R01 GM	Regulation of IL-2 Gene Expression in T-cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities	$297,000
NIH 2003 R01 GM	Regulation of IL-2 Gene Expression in T-cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities	$297,000
NIH 2002 R01 GM	Regulation of IL-2 Gene Expression in T-cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities	$297,000
NIH 2000 R01 GM	Regulation of IL-2 Gene Expression in T Cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities	$72,309
NIH 1999 R01 GM	Regulation of IL-2 Gene Expression in T Cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities
NIH 1998 R01 GM	Regulation of IL-2 Gene Expression in T Cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities
NIH 1997 R01 GM	Regulation of IL-2 Gene Expression in T Cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities
NIH 1996 R01 GM	Regulation of IL-2 Gene Expression in T Cell Anergy Mueller, Daniel L. / University of Minnesota Twin Cities

Publications

Agarwal, Pujya; Raghavan, Arvind; Nandiwada, Sarada L et al. (2009) Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 183:1695-704

Zhang, Ruan; Zhang, Na; Mueller, Daniel L (2008) Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion. J Immunol 181:5331-9

Mondino, Anna; Mueller, Daniel L (2007) mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol 19:162-72

Bonnevier, Jody L; Yarke, Cory A; Mueller, Daniel L (2006) Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G1-->S phase transitions at an optimal rate. Eur J Immunol 36:1583-97

Nandiwada, Sarada L; Li, Wei; Zhang, Ruan et al. (2006) p300/Cyclic AMP-responsive element binding-binding protein mediates transcriptional coactivation by the CD28 T cell costimulatory receptor. J Immunol 177:401-13

Vanasek, Tracy L; Nandiwada, Sarada L; Jenkins, Marc K et al. (2006) CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol 176:5880-9

Bonnevier, Jody L; Zhang, Ruan; Mueller, Daniel L (2005) E3 ubiquitin ligases and their control of T cell autoreactivity. Arthritis Res Ther 7:233-42

Mueller, Daniel L (2004) E3 ubiquitin ligases as T cell anergy factors. Nat Immunol 5:883-90

Bonnevier, Jody L; Mueller, Daniel L (2002) Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J Immunol 169:6659-63

Li, W; Whaley, C D; Bonnevier, J L et al. (2001) CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation. J Immunol 167:827-35

Showing the most recent 10 out of 13 publications

Comments

Be the first to comment on Daniel Mueller's grant